Increased circulating platelet-derived extracellular vesicles in severe COVID-19 disease

References

• Levi M, Thachil J, Iba T, Levy JH. Coagulation abnormalities and thrombosis in patients with COVID-19. The Lancet Haematology. 2020;7(6):438–9. doi:10.1016/S2352-3026(20)30145-9.
   PubMed Web of Science ®Google Scholar
• Helin TA, Lemponen M, Lahtiharju T, Koskinen M, Lassila R, Joutsi-Korhonen L. Anaemia and enhancement of coagulation are associated with severe COVID-19 infection. Scand J Clin Lab Invest. 2021;81(8):653–60. doi:10.1080/00365513.2021.2001845.
   PubMed Web of Science ®Google Scholar
• Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. (London, England). 2020;395(10229):1054–62. doi:10.1016/S0140-6736(20)30566-3.
   PubMed Web of Science ®Google Scholar
• Koupenova M, Livada AC, Morrell CN. Platelet and megakaryocyte roles in innate and adaptive immunity. Circ Res. 2022;130(2):288–308. doi:10.1161/CIRCRESAHA.121.319821.
   PubMed Web of Science ®Google Scholar
• Puhm F, Flamand L, Boilard E. Platelet extracellular vesicles in COVID-19: potential markers and makers. J Leukoc Biol. 2022;111(1):63–74. doi:10.1002/JLB.3MIR0221-100R.
   PubMed Web of Science ®Google Scholar
• Gasecka A, Nieuwland R, Siljander P-M. Platelet-Derived extracellular vesicles. In: Michelson A, Cattaneo M, Frelinger A, and Newman P. editors. Platelets 4th ed. Cambridge (USA): Academic Press;2019. p. 401–16. doi:10.1016/B978-0-12-813456-6.00022-9.
   Google Scholar
• Yates AG, Pink RC, Erdbrügger U, Siljander PR, Dellar ER, Pantazi P, Akbar N, Cooke WR, Vatish M, Dias‐Neto E. et al. In sickness and in health: the functional role of extracellular vesicles in physiology and pathology in vivo. J Extracell Vesicles. 2022;11(1). doi: 10.1002/jev2.12190.
   Web of Science ®Google Scholar
• Cappellano G, Raineri D, Rolla R, Giordano M, Puricelli C, Vilardo B, Manfredi M, Cantaluppi V, Sainaghi PP, Castello L. et al. Circulating platelet-derived extracellular vesicles are a hallmark of Sars-Cov-2 infection. Cells. 2021;10(1):85. doi: 10.3390/cells10010085.
   PubMed Web of Science ®Google Scholar
• Ayers L, Pink R, Carter DRF, Nieuwland R. Clinical requirements for extracellular vesicle assays. J Extracell Vesicles. 2019;8(1). doi:10.1080/20013078.2019.1593755.
   PubMed Web of Science ®Google Scholar
• Welsh JA, Arkesteijn GJA, Bremer M, Cimorelli M, Dignat-George F, Giebel B, Görgens A, Hendrix A, Kuiper M, Lacroix R. et al. A compendium of single extracellular vesicle flow cytometry. J Extracell Vesicles. 2023;12(2). doi: 10.1002/jev2.12299.
   Web of Science ®Google Scholar
• Arab T, Mallick ER, Huang Y, Dong L, Liao Z, Zhao Z, Gololobova O, Smith B, Haughey NJ, Pienta KJ. et al. Characterization of extracellular vesicles and synthetic nanoparticles with four orthogonal single-particle analysis platforms. J Extracell Vesicles. 2021;10(6):e12079. doi:10.1002/jev2.12079.
   PubMed Web of Science ®Google Scholar
• Maaninka K, Neuvonen M, Kerkelä E, Hyvärinen K, Palviainen M, Kamali-Moghaddam M, Federico A, Greco D, Laitinen S, Öörni K. et al. OxLDL sensitizes platelets for increased formation of extracellular vesicles capable of finetuning macrophage gene expression. Eur J Cell Biol. 2023;102(2):151311. doi:10.1016/j.ejcb.2023.151311.
   PubMed Web of Science ®Google Scholar
• Welsh JA, van der Pol E, Arkesteijn GJA, Bremer M, Brisson A, Coumans F, Dignat-George F, Duggan E, Ghiran I, Giebel B. et al. MIFlowCyt-EV: a framework for standardized reporting of extracellular vesicle flow cytometry experiments. J Extracell Vesicles. 2020;9(1). doi: 10.1080/20013078.2020.1713526.
   Web of Science ®Google Scholar
• Thachil J, Tang N, Gando S, Falanga A, Cattaneo M, Levi M, Clark C, Iba T. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost. 2020;18(5):1023–6. doi:10.1111/jth.14810.
   PubMed Web of Science ®Google Scholar
• Iba T, Levy JH, Levi M, Thachil J. Coagulopathy in COVID-19. J Thromb Haemost. 2020;18(9):2103–9. doi:10.1111/jth.14975.
   PubMed Web of Science ®Google Scholar
• Zaid Y, Puhm F, Allaeys I, Naya A, Oudghiri M, Khalki L, Limami Y, Zaid N, Sadki K, ben El Haj R. et al. Platelets can associate with SARS-Cov-2 RNA and are hyperactivated in COVID-19. Circ Res. 2020;127(11):1404–18. doi:10.1161/CIRCRESAHA.120.317703.
   PubMed Web of Science ®Google Scholar
• Pesce E, Manfrini N, Cordiglieri C, Santi S, Bandera A, Gobbini A, Gruarin P, Favalli A, Bombaci M, Cuomo A. et al. Exosomes recovered from the plasma of COVID-19 patients expose SARS-CoV-2 spike-derived fragments and contribute to the adaptive immune response. Front Immunol. 2022;12:12. doi: 10.3389/FIMMU.2021.785941.
   Web of Science ®Google Scholar
• Burgelman M, Vandendriessche C, Vandenbroucke RE. Extracellular vesicles: a double-edged sword in sepsis. Pharmaceuticals. 2021;14(8):829. (Basel, Switzerland). doi: 10.3390/PH14080829.
   Web of Science ®Google Scholar
• Kerris EWJ, Hoptay C, Calderon T, Freishtat RJ. Platelets and platelet extracellular vesicles in hemostasis and sepsis. J Investig Med. 2020;68(4):813–20. doi:10.1136/JIM-2019-001195.
   PubMed Web of Science ®Google Scholar
• Babkina AS, Ostrova IV, Yadgarov MY, Kuzovlev AN, Grechko AV, Volkov AV, Golubev AM. The role of Von Willebrand factor in the pathogenesis of pulmonary vascular thrombosis in COVID-19. Haemophilia. 2022;Suppl 14(Suppl 2):211–7. doi:10.3390/v14020211.
   Google Scholar
• Siljander P, Carpen O, Lassila R. Platelet-derived microparticles associate with fibrin during thrombosis. Blood. 1996;87(11):4651–63. doi:10.1182/BLOOD.V87.11.4651.BLOODJOURNAL87114651.
   PubMed Web of Science ®Google Scholar
• Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Structure VD. Function, and antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell. 2020;181(2):281–92.e6. doi:10.1016/J.CELL.2020.02.058.
   PubMed Web of Science ®Google Scholar
• Bury L, Camilloni B, Castronari R, Piselli E, Malvestiti M, Borghi M, Kuchibotla H, Falcinelli E, Petito E, Amato F. et al. Search for SARS-CoV-2 RNA in platelets from COVID-19 patients. Platelets. 2021;32(2):284–7. doi: 10.1080/09537104.2020.1859104.
   PubMed Web of Science ®Google Scholar
• Campbell RA, Boilard E, Rondina MT. Is there a role for the ACE2 receptor in SARS-CoV-2 interactions with platelets? J Thromb Haemost. 2021;19(1):46–50. doi:10.1111/JTH.15156.
   PubMed Web of Science ®Google Scholar
• Zhang S, Liu Y, Wang X, Yang L, Li H, Wang Y, Liu M, Zhao X, Xie Y, Yang Y. et al. SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19. J Hematol Oncol. 2020;13(1). doi: 10.1186/S13045-020-00954-7.
   Web of Science ®Google Scholar
• Kanth Manne B, Denorme F, Middleton EA, Portier I, Rowley JW, Stubben C, Petrey AC, Tolley ND, Guo L, Cody M. et al. Platelet gene expression and function in patients with COVID-19. Blood. 2020;136(11):1317–29. doi: 10.1182/BLOOD.2020007214.
   PubMed Web of Science ®Google Scholar
• Vettori M, Carpenè G, Salvagno GL, Gelati M, Dima F, Celegon G, Favaloro EJ, Lippi G. Effects of recombinant SARS-CoV-2 spike protein variants on platelet morphology and activation. Semin Thromb Hemost. 2023. doi:10.1055/s-0043-1769939.
   PubMed Web of Science ®Google Scholar
• Barbosa LC, Gonçalves TL, de Araujo LP, de O RL, Ferrer VP. Endothelial cells and SARS-CoV-2: an intimate relationship. Vascul Pharmacol. 2021;137:106829. doi:10.1016/J.VPH.2021.106829.
   PubMed Web of Science ®Google Scholar
• Joffre J, Hellman J, Ince C, Ait-Oufella H. Endothelial responses in sepsis. Am J Respir Crit Care Med. 2020;202(3):361–70. doi:10.1164/RCCM.201910-1911TR.
   PubMed Web of Science ®Google Scholar
• Sjöström A, Wersäll J, Warnqvist A, Farm M, Magnusson M, Oldner A, Ågren A, Antovic J, Bruzelius M. Platelet count rose while D-Dimer levels dropped as deaths and thrombosis declined-an observational study on anticoagulation shift in COVID-19. Thromb Haemostasis. 2021;121(12):1610–21. doi:10.1055/A-1477-3829.
   PubMed Web of Science ®Google Scholar
• Yang J, Wu Z, Long Q, Huang J, Hong T, Liu W, Lin J. Insights into immunothrombosis: the interplay among neutrophil extracellular trap, von Willebrand factor, and ADAMTS13. Front Immunol. 2020;11:610696. doi:10.3389/fimmu.2020.610696.
   PubMed Web of Science ®Google Scholar
• Mancini I, Baronciani L, Artoni A, Colpani P, Biganzoli M, Cozzi G, Novembrino C, Boscolo Anzoletti M, de Zan V, Pagliari MT. et al. The ADAMTS13-von Willebrand factor axis in COVID-19 patients. J Thromb Haemost. 2021;19(2):513–21. doi: 10.1111/JTH.15191.
   PubMed Web of Science ®Google Scholar
• Chen J, Chung DW. Inflammation, von Willebrand factor, and ADAMTS13. Blood. 2018;132(2):141–7. doi:10.1182/BLOOD-2018-02-769000.
   PubMed Web of Science ®Google Scholar
• Katneni UK, Alexaki A, Hunt RC, Schiller T, DiCuccio M, Buehler PW, Ibla JC, Kimchi-Sarfaty C. Coagulopathy and thrombosis as a result of severe COVID-19 infection: a microvascular focus. Thromb Haemostasis. 2020. doi:10.1055/s-0040-1715841.
   PubMed Web of Science ®Google Scholar
• Bazzan M, Montaruli B, Sciascia S, Cosseddu D, Norbiato C, Roccatello D. Low ADAMTS 13 plasma levels are predictors of mortality in COVID-19 patients. Intern Emerg Med. 2020;15(5):861–3. doi:10.1007/s11739-020-02394-0.
   PubMed Web of Science ®Google Scholar
• Raineri D, Venegoni C, Calella MG, Vaschetto R, Scotti L, Canciani E, Manfredi M, Gavelli F, Castello L, Chiocchetti A. et al. Worse disease Prognosis is associated to an increase of platelet-derived extracellular vesicles in hospitalized SARS-CoV-2 patients. Dis Markers. 2022;2022:1–6. doi: 10.1155/2022/8074655.
   Web of Science ®Google Scholar
• Williams JO, Nash J, Whelan C, Raven BM, Davies AJ, Evans J, Watkeys L, Morris K, James PE. Early but reversible haemostatic changes in asymptomatic females expressing COVID-19 antibodies. Thromb Res. 2022;217:76–85. doi:10.1016/j.thromres.2022.07.012.
   PubMed Web of Science ®Google Scholar